Skip to search formSkip to main contentSkip to account menu

NRX 194204

Known as: NRX-194204, NRX194204, Rexinoid NRX 194204 
An orally bioavailable synthetic retinoid X receptor (RXR) agonist with potential antineoplastic and anti-inflammatory activities. Rexinoid NRX… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
‘BRSIPR Bel' e uma cultivar de batata para processamento industrial na forma de “chips” e batata palha, com tuberculos ovalados… 
2010
2010
Downlo creatic cancer is the fourth leading cause of cancer-related deaths in the United States and is nearly s fatal. Whereas… 
2009
2009
The transcription factor KLF4 functions in post-mitotic epithelial cells to promote differentiation, and functions in a context… 
2008
2008
Purpose: Anaplastic thyroid carcinoma is rare, yet lethal despite aggressive therapy. Molecular targeting may be beneficial using… 
2007
2007
Purpose: We evaluated the anti-inflammatory and growth-inhibitory properties of the novel rexinoid NRX194204 (4204) in vitro and… 
2007
2007
Purpose:To test whether a novel rexinoid, LG100268, prevents the development of preinvasive and invasive estrogen receptor… 
Review
2007
Review
2007
Purpose:We evaluated the anti-inflammatory and growth-inhibitory properties of the novel rexinoid NRX194204 (4204) in vitro and… 
2005
2005
Aims/hypothesisThis study evaluated the hypothesis that peroxisome proliferator-activated receptor-γ (PPARγ) agonists, including… 
Review
2002
Review
2002
The recent elucidation of several molecular paradigms by which retinoids regulate growth, differentiation, and apoptosis…